Verana Health and Bitfount Detail AI Prescreening for Eye Trials
Verana Health and Bitfount detail their previously disclosed collaboration on patient prescreening for ophthalmic clinical trials in a press release. The system combines ophthalmic images with electronic health record data to assess patients against trial criteria.
Bitfount analyzes existing optical coherence tomography or fundus scans locally at participating sites. It sends an imaging eligibility flag to Verana Trial Connect, where researchers can view it alongside criteria derived from health records. Results are also available through Bitfount's on premises application.
The companies say the process can reduce manual chart reviews and screen failures without changing existing imaging systems or data privacy procedures. The approach was clinically validated in a study with Moorfields Eye Hospital.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 22 SEIDOR launches a factory to build AI agents for SAP ERP Nov 21 Databricks in early talks to raise funds at about $225 billion valuation, WSJ reports Nov 21 AWS Quick adds chat-built flows, multi-agent answers and an updated web app Nov 21 Hitachi Digital launches HARC Compose to govern agentic engineering Nov 20 Auterion and SkyFall plan German factory to build drones for UkraineMore from Life Sciences
Nov 22 MedInTech raises $25.7 million for AI robotic endoscopes Nov 21 ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR Nov 21 Chelsea and Westminster Hospital launches multilingual AI avatar platform for lung cancer patients Nov 21 ChatGPT Health reaches Android, desktop and dots; health chats now follow the training setting Nov 20 OpenAI launches MedChemBench to test AI models on medicinal chemistry reasoningEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
nference and Novo Nordisk partner on AI research into obesity, diabetes and heart disease
Banner Health invests in Layer Health and moves its clinical registries onto its AI platform
Atlas Bio raises $12.5 million for virtual drug trials
Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics
Dyania Health and Nvidia bring clinical reasoning AI inside hospital networks
Daily AI Brief: the AI news that matters, in your inbox.